Related Experiment Videos
Virus-induced sarcoma of mice: inhibition by a synthetic polyribonucleotide complex
Abstract:
The availability of a potent inducer of interferon, the synthetic double-stranded RNA (poly I.poly C), prompted us to determine its possible prophylactic and/or therapeutic effect on virus-induced sarcomas of mice. When treatment was begun prior to virus inoculation and repeated on alternate days, the majority of NIH Swiss mice inoculated with Moloney or Friend pseudotypes of Moloney murine sarcoma virus failed to develop tumors. Other experiments suggested that repeated injections initiated even after the establishment of tumor nodules were also effective. Mice injected on the day of birth with poly I.poly C develop high titers of interferon. The evidence favors, but does not establish, the interpretation that the observed tumor inhibition is mediated through the induction of endogenous interferon. These experiments demonstrate that treatment with poly I.poly C is followed by a regression of established murine sarcoma infection in mice.
Insights
Synthetic double-stranded RNA (poly I.poly C) showed prophylactic and therapeutic effects against virus-induced sarcomas in mice. This interferon inducer prevented tumor formation and promoted regression of established tumors.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Virus-induced sarcomas pose a significant challenge in cancer research.
- Interferon, a key antiviral and antitumor mediator, has been explored for therapeutic potential.
Purpose of the Study:
- To investigate the prophylactic and therapeutic efficacy of poly I.poly C, a potent interferon inducer, against murine sarcoma virus.
- To explore the role of endogenous interferon in mediating the observed anti-tumor effects.
Main Methods:
- NIH Swiss mice were inoculated with Moloney or Friend pseudotypes of Moloney murine sarcoma virus.
- Treatment with poly I.poly C was administered either before virus inoculation or after tumor establishment.
- Interferon titers were measured in mice injected with poly I.poly C on the day of birth.
Main Results:
- Prophylactic treatment with poly I.poly C significantly inhibited tumor development in the majority of mice.
- Therapeutic administration of poly I.poly C led to the regression of established tumor nodules.
- Mice treated with poly I.poly C on the day of birth exhibited high interferon titers.
Conclusions:
- Poly I.poly C demonstrates significant potential as both a prophylactic and therapeutic agent against murine sarcoma virus.
- The findings suggest that the anti-tumor effects are likely mediated by the induction of endogenous interferon.
- Further research is warranted to establish the definitive role of interferon in mediating tumor regression.